“Bankruptcy For Moderna, Definitely Pfizer”
Pfizer and Moderna stocks have tanked over liabilty worries. The case made by vocal critic Edward Dowd.
Read more...Pfizer and Moderna stocks have tanked over liabilty worries. The case made by vocal critic Edward Dowd.
Read more...Why Antarctica is a huge wild card in the progress of sea level rises.
Read more...Americans are not happy despite a not at all bad economy leaving most with higher savings and pay than pre-Covid.
Read more...A look at the commodities that are most vulnerable to reduced supply from Russia.
Read more...We predicted the new CDC head, Rochelle Walensky, would do badly. A New York Times story shows how she’s underperforming our low expectations
Read more...FTI Consulting 2015 slides tout “discrediting” science, “debunking” documentaries, and hype its fracking industry project Energy In Depth
Read more...Gail Tverberg throws cold water on green energy optimism.
Read more...The officialdom is not giving straight answers to simple questions about how much it spent procuring those “free” Covid tests.
Read more...James K. Galbraith discusses the shift of the US from industrialism to his so-called predator state: finance-led, military-centered corporatism
Read more...In How Novelty and Narratives Drive the Stock Market, economist Nicholas Mangee examines how stories influence stock market outcomes
Read more...Efforts to cure inflation, at least for poorer countries, will prove to be more damaging than the disease.
Read more...Don’t get us wrong. We really like EPI. But a new piece on Covid’s impact on low income workers has good analysis and out of date proposals.
Read more...The IMF seems unable to drop its punitive, self and “client” destructive habits.
Read more...regulators can step in to ensure drug pricing both supports patient access and drug development.
Read more...Climate activist: The arguments made against nuclear power today are the same as I was making a decade ago, and I was wrong.
Read more...